[Treatment with psychedelics : potential benefits in Parkinson's disease].
Revue medicale suisse April 23, 2025 Louise Penzenstadler, Sandra Baudois, Alma Lingenberg et al.
Psychedelics, such as psilocybin and lysergic acid diethylamide, modulate neuroplasticity and brain connectivity via 5-HT2A receptors. Their efficacy has been demonstrated in depression and anxiety, where they are particularly interesting because of their rapid and long-lasting effect. They could also be beneficial for addictions, post-traumatic stress, and obsessive-compulsive disorder. This...